The Scottish Medicines Consortium (SMC) has issued advice on eight different medicines, advising healthcare professionals as to whether they have been accepted for use, accepted for restricted use, or not recommended for use in NHS Scotland.
The medicines are listed under the following British National Formulary categories:
Central nervous system
- Drugs used in nausea and vertigo
- aprepitant—accepted for use
- Drugs used in substance dependence
- buprenorphine oral lyophilisate—accepted for restricted use.
- Drugs affecting intestinal secretions
- obeticholic acid—accepted for use.
Malignant disease and immmunosuppresion
Nutrition and blood
- Anaemias and some other blood disorders
- deferasirox—accepted for restricted use.
- budesonide-formoterol—accepted for use.
- Preparations for eczema and psoriasis
- adalimumab—accepted for use.
The SMC aims to ensure that newly licensed medications representing good value for money are accepted for routine use in NHS Scotland as quickly as possible. It does this by bringing together a consortium that is made up of lead clinicians, pharmacists, and health economists, as well as representatives from health boards, the pharmaceutical industry, and the public.